JOSÉ MARÍA
GUINEA DE CASTRO
Institute Catalá Oncología
Barcelona, EspañaInstitute Catalá Oncología -ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2015
-
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433